Self-Efficacy and Medication Adherence in Patients With Coronary Artery Disease: A Descriptive Study

Study acronym: SEMACAD
StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 7 more changesShow less
    • Final enrollment: 150 participants (planned 135)
    • Primary completion date changed from estimate of Oct 1, 2025 to Jun 30, 2025
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description revised
    • Site details revised
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 2 words
  2. Secondary endpoints: details revised at 1 of 1 entry
    • Site contact updated
    v2
  3. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This descriptive study aims to examine the relationship between self-efficacy and medication adherence in individuals with coronary artery disease (CAD). The study will be conducted between March and October 2025 at Adıyaman University Training and Research Hospital with a planned sample size of 135 participants. Data will be collected using a Descriptive Information Form, the Self-Efficacy for Managing Chronic Disease Scale, and the Medication Adherence Report Scale (MARS).
Trial Details
NCT Number NCT06943157
Lead Sponsor Hasan Kalyoncu University
Conditions
(from sponsor)		 Coronary Artery Disease
Related terms Coronary Artery Disease, Medication Adherence
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov